Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements

Journal of Industrial Microbiology and Biotechnology

Volumn 39, Issue 3, 2012, Pages 383-399

  Huang, Chung Jr ^a   Lin, Henry ^a   Yang, Xiaoming ^a  

^a AMGEN INC   (United States)

Author keywords

Aglycosylated antibody; Cell free systems; E. coli N linked glycosylation; Escherichia coli; Recombinant therapeutics production

Indexed keywords

FC RECEPTOR; PROTEIN;

CELL FREE SYSTEM; CELL INCLUSION; CYTOPLASM; ESCHERICHIA COLI; FED BATCH FERMENTATION; FEEDING; FERMENTATION; GLYCOSYLATION; HOST; INDUSTRIAL PRODUCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; SCALE UP; VECTOR CONTROL;

ANIMALS; ANTIBODIES; BIOTECHNOLOGY; CELL-FREE SYSTEM; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FERMENTATION; GLYCOSYLATION; PROTEIN ENGINEERING; PROTEIN FOLDING; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84863303532     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-011-1082-9     Document Type: Review

References (133)

1. Alibolandi M, Mirzahoseini H, Abad MAK, Azami movahed M (2010) High level expression of human basic Wbroblast growth factor in Escherichia coli: evaluating the eVect of the GC content and rare codons within the Wrst 13 codons. Afr J Biotechnol 9(16):2456-2462
2. Andersen DC, Reilly DE (2004) Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15(5):456-462 (Pubitemid 39304044)
3. Andrews B, Adari H, Hannig G, Lahue E, Gosselin M, Martin S, Ahmed A, Ford PJ, Hayman EG, Makrides SC (1996) A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: production of the human T cell receptor V beta 5.3 in Escherichia coli. Gene 182(1-2):101-109 (Pubitemid 27007172)
4. Babaeipour V, Shojaosadati SA, Robatjazi SM, Khalilzadeh R, Maghsoudi N (2007) Over-production of human interferon-gamma by HCDC of recombinant Escherichia coli. Process Biochem 42(1):112-117 (Pubitemid 44738654)
5. Backlund E, Reeks D, Markland K, Weir N, Bowering L, Larsson G (2008) Fedbatch design for periplasmic product retention in Escherichia coli. J Biotechnol 135(4):358-365
6. Balbas P (2001) Understanding the art of producing protein and nonprotein molecules in Escherichia coli. Mol Biotechnol 19(3):251-267 (Pubitemid 33063507)
7. Baneyx F (1999) Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 10(5):411-421 (Pubitemid 29457264)
8. Bessette PH, Aslund F, Beckwith J, Georgiou G (1999) EYcient folding of proteins with multiple disulWde bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 96(24):13703-13708
9. Calhoun KA, Swartz JR (2006) Total amino acid stabilization during cell-free protein synthesis reactions. J Biotechnol 123(2):193-203
10. Caparon MH, Rust KJ, Hunter AK, McLaughlin JK, Thomas KE, Herberg JT, Shell RE, Lanter PB, Bishop BF, DuWeld RL, Wang X, Ho SV (2010) Integrated solution to puriWcation challenges in the manufacture of a soluble recombinant protein in E. coli. Biotechnol Bioeng 105(2):239-249
11. Carnes AE, Hodgson CP, Williams JA (2006) Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem 45(3):155-166 (Pubitemid 44690220)
12. Carrier TA, Keasling JD (1997) Controlling messenger RNA stability in bacteria: strategies for engineering gene expression. Biotechnol Prog 13(6):699-708 (Pubitemid 28022012)
13. Cascaval D, Galaction AI, Camarut S (2011) Scale-up of aerobic stirred bioreactors using the mixing time criteria 1. simulated broths. Chem Biochem Eng Q 25(1):43-54
14. Chen C, Snedecor B, Nishihara JC, Joly JC, McFarland N, Andersen DC, Battersby JE, Champion KM (2004) High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol Bioeng 85(5):463-474 (Pubitemid 38268662)
15. Choi JH, Keum KC, Lee SY (2006) Production of recombinant proteins by high cell density culture of Escherichia coli. Chem Eng Sci 61(3):876-885 (Pubitemid 41650182)
16. Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64(5):625-635 (Pubitemid 38822625)
17. DeLisa MP, Tullman D, Georgiou G (2003) Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci USA 100(10):6115-6120 (Pubitemid 36576940)
18. Eiberle MK, Jungbauer A (2010) Technical refolding of proteins: do we have freedom to operate? Biotechnol J 5(6):547-559
19. Eiteman MA, Altman E (2006) Overcoming acetate in Escherichia coli recombinant protein fermentations. Trends Biotechnol 24(11):530-536 (Pubitemid 44537454)
20. Enfors SO, Jahic M, Rozkov A, Xu B, Hecker M, Jurgen B, Kruger E, Schweder T, Hamer G, O'Beirne D, Noisommit-Rizzi N, Reuss M, Boone L, Hewitt C, McFarlane C, Nienow A, Kovacs T, Tragardh C, Fuchs L, Revstedt J, Friberg PC, Hjertager B, Blomsten G, Skogman H, Hjort S, Hoeks F, Lin HY, Neubauer P, van der Lans R, Luyben K, Vrabel P, Manelius A (2001) Physiological responses to mixing in large scale bioreactors. J Biotechnol 85(2):175-185 (Pubitemid 32124719)
21. Fahnert B, Lilie H, Neubauer P (2004) Inclusion bodies: formation and utilisation. Adv Biochem Eng Biotechnol 89:93-142
22. Fang Z (2010) Applying computational Xuid dynamics technology in bioprocesses. Biopharm Int 23(4):38
23. Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, Morris HR, Dell A, Valvano MA, Aebi M (2005) Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci USA 102(8):3016-3021 (Pubitemid 40299908)
24. Fernandez LA, Sola I, Enjuanes L, de Lorenzo V (2000) SpeciWc secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system. Appl Environ Microbiol 66(11):5024-5029
25. Ferrer-Miralles N, Domingo-Espín J, Corchero J, Vázquez E, Villaverde A (2009) Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 8(1):17
26. Fisher AC, Haitjema CH, Guarino C, Celik E, Endicott CE, Reading CA, Merritt JH, Ptak AC, Zhang S, DeLisa MP (2011) Production of secretory and extracellular N-Linked glycoproteins in Escherichia coli. Appl Environ Microbiol 77(3):871-881
27. Friehs K (2004) Plasmid copy number and plasmid stability. Adv Biochem Eng Biotechnol 86:47-82
28. Furman TC, Epp J, Hsiung HM, Hoskins J, Long GL, Mendelsohn LG, Schoner B, Smith DP, Smith MC (1987) Recombinant human insulin-like growth factor-I expressed in Escherichia coli. Bio-Technology 5(10):1047-1051
29. Graumann K, Premstaller A (2006) Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnol J 1(2):164-186
30. Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22(7):346-353 (Pubitemid 38887543)
31. Gvritishvili AG, Leung KW, Tombran-Tink J (2010) Codon preference optimization increases heterologous PEDF expression. PLoS ONE 5(11):e15056
32. Harrison JS, Keshavarz-Moore E (1996) Production of antibody fragments in Escherichia coli. Ann NY Acad Sci 782:143-158 (Pubitemid 26194712)
33. Huang CJ, Chen RH, Vannelli T, Lee F, Ritter E, Ritter G, Old LJ, Batt CA (2007) Expression and puriWcation of the cancer antigen SSX2: a potential cancer vaccine. Protein Expr Purif 56(2):212-219 (Pubitemid 47633222)
34. Huang CJ, Lowe AJ, Batt CA (2010) Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market. Appl Microbiol Biotechnol 87(2):401-410
35. Huang YS, Chen Z, Chen YQ, Ma GC, Shan JF, Liu W, Zhou LF (2008) Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris. J Pept Sci 14(5):588-595 (Pubitemid 351736454)
36. Islam RS, Tisi D, Levy MS, Lye GJ (2008) Scale-up of Escherichia coli growth and recombinant protein expression conditions from microwell to laboratory and pilot scale based on matched kLa. Biotechnol Bioeng 99(5):1128-1139 (Pubitemid 351462772)
37. Ivanov AV, Korovina AN, Tunitskaya VL, Kostyuk DA, Rechinsky VO, Kukhanova MK, Kochetkov SN (2006) Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins. Protein Expr Purif 48(1):14-23 (Pubitemid 43782621)
38. Jana S, Deb JK (2005) Strategies for eYcient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol 67(3):289-298 (Pubitemid 40684730)
39. Jensen EB, Carlsen S (1990) Production of recombinant human growth hormone in Escherichia coli: Expression of diVerent precursors and physiological eVects of glucose, acetate, and salts. Biotechnol Bioeng 36(1):1-11 (Pubitemid 20210769)
40. Jewett MC, Swartz JR (2004) Mimicking the Escherichia coli cytoplasmic environment activates long-lived and eYcient cellfree protein synthesis. Biotechnol Bioeng 86(1):19-26 (Pubitemid 38339387)
41. Jiang XR, Song A, Bergelson S, Arroll T, Parekh B, May K, Chung S, Strouse R, Mire-Sluis A, Schenerman M (2011) Advances in the assessment and control of the eVector functions of therapeutic antibodies. Nat Rev Drug Discov 10(2):101-110
42. Jobe AM, Herwig C, Surzyn M, Walker B, Marison I, von Stockar U (2003) Generally applicable fed-batch culture concept based on the detection of metabolic state by on-line balancing. Biotechnol Bioeng 82(6):627-639 (Pubitemid 36576226)
43. Joly JC, Leung WS, Swartz JR (1998) Overexpression of Escherichia coli oxidoreductases increases recombinant insulin-like growth factor-I accumulation. Proc Natl Acad Sci USA 95(6):2773-2777 (Pubitemid 28135804)
44. Jong WSP, Saurí A, Luirink J (2010) Extracellular production of recombinant proteins using bacterial autotransporters. Curr Opin Biotechnol 21(5):646-652
45. Jung ST, Kang TH, Kelton W, Georgiou G (2011) Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy. Curr Opin Biotechnol 22(6):858-867
46. Jung ST, Reddy ST, Kang TH, Borrok MJ, Sandlie I, Tucker PW, Georgiou G (2010) Aglycosylated IgG variants expressed in bacteria that selectively bind Fc gamma RI potentiate tumor cell killing by monocyte-dendritic cells. Proc Natl Acad Sci USA 107(2):604-609
47. Junker BH (2004) Scale-up methodologies for Escherichia coli and yeast fermentation processes. J Biosci Bioeng 97(6):347-364 (Pubitemid 38980915)
48. Kamionka M (2011) Engineering of therapeutic proteins production in Escherichia coli. Curr Pharm Biotechnol 12(2):268-274
49. Kanemori M, Nishihara K, Yanagi H, Yura T (1997) Synergistic roles of HslVU and other ATP-dependent proteases in controlling in vivo turnover of sigma32 and abnormal proteins in Escherichia coli. J Bacteriol 179(23):7219-7225 (Pubitemid 27509956)
50. Kim SG, Shin SY, Park YC, Shin CS, Seo JH (2011) Production and solid-phase refolding of human glucagon-like peptide-1 using recombinant Escherichia coli. Protein Expr Purif 78(2):197-203
51. Kleman GL, Chalmers JJ, Luli GW, Strohl WR (1991) A predictive and feedback control algorithm maintains a constant glucose concentration in fed-batch fermentations. Appl Environ Microbiol 57(4):910-917
52. Knapp KG, Goerke AR, Swartz JR (2007) Cell-free synthesis of proteins that require disulWde bonds using glucose as an energy source. Biotechnol Bioeng 97(4):901-908 (Pubitemid 47051059)
53. Kolaj O, Spada S, Robin S, Wall JG (2009) Use of folding modulators to improve heterologous protein production in Escherichia coli. Microb Cell Fact 8:9
54. Koo TY, Park TH (1999) Increased production of recombinant protein by Escherichia coli deWcient in acetic acid formation. J Microbiol Biotechnol 9(6):789-793 (Pubitemid 30036011)
55. Kowarik M, Young NM, Numao S, Schulz BL, Hug I, Callewaert N, Mills DC, Watson DC, Hernandez M, Kelly JF, Wacker M, Aebi M (2006) DeWnition of the bacterial N-glycosylation site consensus sequence. EMBO J 25(9):1957-1966
56. Labrijn AF, Aalberse RC, Schuurman J (2008) When binding is enough: nonactivating antibody formats. Curr Opin Immunol 20(4):479-485
57. Lee SY (1996) High cell-density culture of Escherichia coli. Trends Biotechnol 14(3):98-105 (Pubitemid 26079509)
58. Levisauskas D (2001) Inferential control of the speciWc growth rate in fed-batch cultivation processes. Biotechnol Lett 23(15):1189-1195 (Pubitemid 32781184)
59. Liddell JM (2009) Production strategies for antibody fragment therapeutics. Biopharm Int Suppl 22(6):36-42
60. Lilie H, Schwarz E, Rudolph R (1998) Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol 5:497-501 (Pubitemid 28478971)
61. Liu DV, Zawada JF, Swartz JR (2005) Streamlining Escherichia coli S30 extract preparation for economical cell-free protein synthesis. Biotechnol Prog 21(2):460-465 (Pubitemid 40466418)
62. Lizak C, Fan YY, Weber TC, Aebi M (2011) N-Linked glycosylation of antibody fragments in Escherichia coli. Bioconjug Chem 22(3):488-496
63. Lopez PJ, Marchand I, Joyce SA, Dreyfus M (1999) The Cterminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo. Mol Microbiol 33(1):188-199 (Pubitemid 29304199)
64. Lowe AJ, Bardliving CL, Huang CJ, Teixeira LM, Damasceno LM, Anderson KA, Ritter G, Old LJ, Batt CA (2011) Expression and puriWcation of cGMP grade NY-ESO-1 for clinical trials. Biotechnol Prog 27(2):435-441
65. Luo Y, Fan DD, Ma XX, Wang DW, Mi Y, Hua XF, Li WH (2005) Process control for production of human-like collagen in fed-batch culture of Escherichia coli BL 21. Chin J Chem Eng 13(2):276-279 (Pubitemid 40778604)
66. Maeng BH, Nam DH, Kim YH (2011) Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Escherichia coli for the detection of Btype natriuretic peptide. World J Microbiol Biotechnol 27(6):1391-1398
67. Makrides SC (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60(3):512-538 (Pubitemid 26303477)
68. Maurizi MR (1992) Proteases and protein-degradation in Escherichia coli. Experientia 48(2):178-201
69. Mavrangelos C, Thiel M, Adamson PJ, Millard DJ, Nobbs S, Zola H, Nicholson IC (2001) Increased yield and activity of soluble single-chain antibody fragments by combining high-level expression and the Skp periplasmic chaperonin. Protein Expr Purif 23(2):289-295 (Pubitemid 33037797)
70. Menart V, Jevsevar S, Vilar M, Trobis A, Pavko A (2003) Constitutive versus thermo inducible expression of heterologous proteins in Escherichia coli based on strong PR, PL promoters from phage lambda. Biotechnol Bioeng 83(2):181-190 (Pubitemid 36734132)
71. Mergulhao FJ, Summers DK, Monteiro GA (2005) Recombinant protein secretion in Escherichia coli. Biotechnol Adv 23(3):177-202 (Pubitemid 40335946)
72. Mucke M, Ostendorp R, Leonhartsberger S (2009) E. coli secretion technologies enable production of high yields of active human antibody fragments. BioProcess Int 7(8):40-47
73. Mureev S, Kovtun O, Nguyen UT, Alexandrov K (2009) Species-independent translational leaders facilitate cell-free expression. Nat Biotechnol 27(8):747-752
74. Nelson AL, Reichert JM (2009) Development trends for therapeutic antibody fragments. Nat Biotechnol 27(4):331-337
75. Ni Y, Chen R (2009) Extracellular recombinant protein production from Escherichia coli. Biotechnol Lett 31(11):1661-1670
76. Ohashi H, Kanamori T, Shimizu Y, Ueda T (2010) A highly controllable reconstituted cell-free system-a breakthrough in protein synthesis research. Curr Pharm Biotechnol 11(3):267-271
77. Pandhal J, Ow SY, Noirel J, Wright PC (2010) Improving N-glycosylation eYciency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring. Biotechnol Bioeng 108:902-912
78. Perezperez J, Martinezcaja C, Barbero JL, Gutierrez J (1995) Dnak/Dnaj supplementation improves the periplasmic production of human granulocyte colony stimulating factor in Escherichia coli. Biochem Biophys Res Commun 210(2):524-529
79. Puigbò P, Guzmán E, Romeu A, Garcia-Vallvé S (2007) OPTIMIZER: a web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res 35:W126-W131
80. Qian ZG, Xia XX, Choi JH, Lee SY (2008) Proteome-based identiWcation of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng 101(3):587-601
81. Rathore A, Krishnan R, Tozer S, Smiley D, Rausch S, Seely J (2005) Scaling down of biopharmaceutical unit operations-part 2: chromatography and Wltration. Biopharm Int 18(4):58
82. Ray MVL, Vanduyne P, Bertelsen AH, Jacksonmatthews DE, Sturmer AM, Merkler DJ, Consalvo AP, Young SD, Gilligan JP, Shields PP (1993) Production of recombinant salmon calcitonin by in vitro amidation of an Escherichia coli produced precursor peptide. Bio-Technology 11(1):64-70 (Pubitemid 23013713)
83. Reilly DE, Yansura DG (2010) Production of monoclonal antibodies in E. coli. In: Shire SJ, Gombotz W, Bechtold-Peters K, Andya J (eds) Current trends in monoclonal antibodies development and manufacturing. Springer, New York, pp 295-308
84. Riscaldati E, Ciabini A, Baccante A, Moscatelli D, Errichetti M, Colagrande A, Cencioni S, Marcocci F, Di Cioccio V, Di Ciccio L, Allegretti M, Martin F, Maurizi G (2006) Set up and optimization of a fermentation protocol for the production of a human antibody fragment (Fab') express in E. coli. Pre-pilot and cGMP pilot scale studies. Microb Cell Fact 5(Suppl 1):P29
85. Rozkov A, Enfors SO (2004) Analysis and control of proteolysis of recombinant proteins in Escherichia coli. Adv Biochem Eng Biotechnol 89:163-195
86. Sahdev S, Khattar SK, Saini KS (2008) Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem 307(1-2):249-264 (Pubitemid 50006245)
87. Salis HM, Mirsky EA, Voigt CA (2009) Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol 27(10):946-950
88. Sazinsky SL, Ott RG, Silver NW, Tidor B, Ravetch JV, Wittrup KD (2008) Aglycosylated immunoglobulin G1variants productively engage activating Fc receptors. Proc Natl Acad Sci USA 105(51):20167-20172
89. Schmidt FR (2005) Optimization and scale up of industrial fermentation processes. Appl Microbiol Biotechnol 68(4):425-435 (Pubitemid 41549986)
90. Schumann W, Ferreira LCS (2004) Production of recombinant proteins in Escherichia coli. Genet Mol Biol 27:442-453 (Pubitemid 43084872)
91. Schwarz F, Huang W, Li CS, Schulz BL, Lizak C, Palumbo A, Numao S, Neri D, Aebi M, Wang LX (2010) A combined method for producing homogeneous glycoproteins with eukaryotic Nglycosylation. Nat Chem Biol 6(4):264-266
92. Sharma SS, Blattner FR, Harcum SW (2007) Recombinant protein production in an Escherichia coli reduced genome strain. Metab Eng 9(2):133-141 (Pubitemid 46329507)
93. Shiloach J, Fass R (2005) Growing E. coli to high cell density-a historical perspective on method development. Biotechnol Adv 23(5):345-357 (Pubitemid 40727987)
94. Shin CS, Hong MS, Bae CS, Lee J (1997) Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2]. Biotechnol Prog 13(3):249-257 (Pubitemid 27253342)
95. Shokri A, Sanden AM, Larsson G (2002) Growth rate-dependent changes in Escherichia coli membrane structure and protein leakage. Appl Microbiol Biotechnol 58(3):386-392 (Pubitemid 34185585)
96. Shokri A, Sanden AM, Larsson G (2003) Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli. Appl Microbiol Biotechnol 60(6):654-664 (Pubitemid 36286671)
97. Simmons LC, Reilly D, Klimowski L, Raju TS, Meng G, Sims P, Hong K, Shields RL, Damico LA, Rancatore P, Yansura DG (2002) Expression of full-length immunoglobulins in Escherichia coli: rapid and eYcient production of aglycosylated antibodies. J Immunol Methods 263(1-2):133-147 (Pubitemid 34493816)
98. Simmons LC, Yansura DG (1996) Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nat Biotechnol 14(5):629-634 (Pubitemid 26135129)
99. Skretas G, Carroll S, DeFrees S, Schwartz MF, Johnson KF, Georgiou G (2009) Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli. Microb Cell Fact 8:50
100. Studier FW, MoVatt BA (1986) Use of bacteriophage T7 RNA Polymerase to direct selective high level expression of cloned genes. J Mol Biol 189(1):113-130
101. Subramanian M, Zeuzem S, Neumann A, Nelson D, Bain V, Balan V, Corey A, Fiscella M (2007) Albinterferon alpha-2b (ALB-IFN): Anti-HCV activity and pharmacokinetics/pharmacodynamics. J Interf Cytok Res 27(8):703
102. Swartz J (2006) Developing cell-free biology for industrial applications. J Ind Microbiol Biotechnol 33(7):476-485 (Pubitemid 43876107)
103. Swartz JR (2001) Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol 12(2):195-201 (Pubitemid 32247408)
104. Szlachcic A, Zakrzewska M, Otlewski J (2011) Longer action means better drug: tuning up protein therapeutics. Biotechnol Adv 29(4):436-441
105. Szymanski CM, Yao RJ, Ewing CP, Trust TJ, Guerry P (1999) Evidence for a system of general protein glycosylation in Campylobacter jejuni. Mol Microbiol 32(5):1022-1030 (Pubitemid 29255768)
106. Tegel H, Tourle S, Ottosson J, Persson A (2010) Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta(DE3). Protein Expr Purif 69(2):159-167
107. Terpe K (2006) Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72(2):211-222 (Pubitemid 44273045)
108. Thomas MD, van Tilburg A (2000) Overexpression of foreign proteins using the Vibrio Wscheri lux control system. Methods Enzymol 305:315-329 (Pubitemid 30421275)
109. Tiwari A, Sankhyan A, Khanna N, Sinha S (2010) Enhanced periplasmic expression of high aYnity humanized scFv against Hepatitis B surface antigen by codon optimization. Protein Expr Purif 74(2):272-279
110. Tripathi NK, Sathyaseelan K, Jana AM, Rao PVL (2009) High yield production of heterologous proteins with Escherichia coli. Def Sci J 59(2):137-146
111. Valdez-Cruz NA, Caspeta L, Perez NO, Ramirez OT, Trujillo-Roldan MA (2010) Production of recombinant proteins in E. coli by the heat inducible expression system based on the phage lambda pL and/or pR promoters. Microb Cell Fact 9:18
112. van de Walle M, Shiloach J (1998) Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation. Biotechnol Bioeng 57(1):71-78 (Pubitemid 27514702)
113. Varley J, Birch J (1999) Reactor design for large scale suspension animal cell culture. Cytotechnology 29(3):177-205 (Pubitemid 29207781)
114. Vasina JA, Baneyx F (1997) Expression of aggregation prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspA and tac promoter systems. Protein Expr Purif 9(2):211-218 (Pubitemid 27210716)
115. Ventura S, Villaverde A (2006) Protein quality in bacterial inclusion bodies. Trends Biotechnol 24(4):179-185
116. Venturi M, Seifert C, Hunte C (2002) High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm. J Mol Biol 315(1):1-8 (Pubitemid 34722107)
117. Vera A, Arís A, Carrió M, González-Montalbán N, Villaverde A (2005) Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies. J Biotechnol 119(2):163-171 (Pubitemid 41219545)
118. Villalobos A, Ness J, Gustafsson C, Minshull J, Govindarajan S (2006) Gene designer: a synthetic biology tool for constructing artiWcial DNA segments. BMC Bioinform 7(1):285
119. Vimberg V, Tats A, Remm M, Tenson T (2007) Translation initiation region sequence preferences in Escherichia coli. BMC Mol Biol 8:100
120. Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, Aebi M (2002) N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 298(5599):1790-1793 (Pubitemid 35404123)
121. Weir ANC, Nesbitt A, Chapman AP, Popplewell AG, Antoniw P, Lawson ADG (2002) Formatting antibody fragments to mediate speciWc therapeutic functions. Biochem Soc Trans 30:512-516 (Pubitemid 35001587)
122. Weuster-Botz D (2000) Experimental design for fermentation media development: statistical design or global random search? J Biosci Bioeng 90(5):473-483 (Pubitemid 32002354)
123. Wilson BS, Kautzer CR, Antelman DE (1994) Increased protein expression through improved ribosome-binding sites obtained by library mutagenesis. Biotechniques 17(5):944-953
124. Wong MS, Wu S, Causey TB, Bennett GN, San KY (2008) Reduction of acetate accumulation in Escherichia coli cultures for increased recombinant protein production. Metab Eng 10(2):97-108
125. Yang J, Moyana T, Mackenzie S, Xia Q, Xiang J (1998) One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF) from Escherichia coli caused by the synergistic eVects of glycine and Triton X-100. Appl Environ Microbiol 64(8):2869-2874 (Pubitemid 28363154)
126. Yang X (2007) Large-scale microbial production technology for human therapeutic products. In: Langer ES (ed) Advances in large-scale biopharmaceutical manufacturing and scale-up production. ASM Press, Washington, pp 329-362
127. Yang XM (1992) Optimization of a cultivation process for recombinant protein production by Escherichia coli. J Biotechnol 23(3):271-289
128. Yee L, Blanch HW (1993) DeWned media optimization for growth of recombinant Escherichia coli X90. Biotechnol Bioeng 41(2):221-230 (Pubitemid 23020412)
129. Yim S, Jeong K, Chang H, Lee S (2001) High-level secretory production of human granulocyte-colony stimulating factor by fed-batch culture of recombinant Escherichia coli. Bioprocess Biosyst Eng 24(4):249-254 (Pubitemid 34031285)
130. Yoon SH, Kim SK, Kim JF (2010) Secretory production of recombinant proteins in Escherichia coli. Recent Pat Biotechnol 4(1):23-29
131. Zawada JF, Yin G, Steiner AR, Yang J, Naresh A, Roy SM, Gold DS, Heinsohn HG, Murray CJ (2011) Microscale to manufacturing scale-up of cell-free cytokine production-a new approach for shortening protein production development timelines. Biotechnol Bioeng 108(7):1570-1578
132. Zhang J, Greasham R (1999) Chemically deWned media for commercial fermentations. Appl Microbiol Biotechnol 51(4):407-421 (Pubitemid 29210560)
133. Zhang W, Xiao W, Wei H, Zhang J, Tian Z (2006) mRNA secondary structure at start AUG codon is a key limiting factor for human protein expression in Escherichia coli. Biochem Biophys Res Commun 349(1):69-78 (Pubitemid 44331764)